ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Study Protocol

Comparison of efficacy of intrathecal fentanyl as an adjuvant to bupivacaine and ropivacaine in lower limb orthopaedic surgeries for post-operative analgesia

[version 1; peer review: awaiting peer review]
PUBLISHED 07 Aug 2023
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS AWAITING PEER REVIEW

This article is included in the Datta Meghe Institute of Higher Education and Research collection.

Abstract

Background: Sub-arachnoid block or spinal anaesthesia is a common mode of anaesthesia that is used for lower limb orthopaedic surgeries. Bupivacaine hydrochloride is a long-acting amide anaesthetic used extensively intrathecally. It has the ability to effectively block sensory and motor pathways. However, it has drawbacks, like cardiotoxicity and neurotoxicity. Ropivacaine is a long-acting amide local anaesthetic agent. It has the capacity to block sensory nerves more than motor nerves. Ropivacaine has reduced potential for neurotoxicity and cardiotoxicity. Fentanyl is a synthetic opioid. It can be added as an adjuvant to local anaesthetic agents used intrathecally. Fentanyl is characterised by its high potency, rapid serum elimination, and minimal histamine release. The blood-brain barrier can be quickly crossed by fentanyl, which takes one to two minutes to generate analgesia.
Objectives: To compare post-operative analgesia in patients receiving bupivacaine with fentanyl and ropivacaine with fentanyl in lower limb orthopaedic surgeries via sub-arachnoid block; onset, duration of analgesia, duration of sensory and motor blockade; study the haemodynamic stability of patients in both groups; compare the requirement of 24 hours rescue analgesia; to compare the incidence of side effects.
Methodology: This study will be a comparative interventional study which will be conducted on 60 adult patients of both sexes posted for lower limb orthopaedic surgery. They will be randomly divided into two groups with 30 patients in both groups. Group A: Patients receiving bupivacaine 3 mL with fentanyl 25 µg and Group B:  Patients receiving ropivacaine 3mL with fentanyl 25 µg. The onset of and duration of block (sensory as well as motor), hemodynamic parameters, post-operative analgesia time and side effects (if any) will be recorded.

Trial registration: Submitted to Clinical Trial Registry of India (CTRI)
Trial REF/2023/05/067586

Keywords

anaesthesia, subarachnoid, bupivacaine, ropivacaine, fentanyl, sensory block, motor block, analgesia

Introduction

Background and rationale

The word “anaesthesia” is derived from the Greek word meaning “loss of sensation”. Insensibility to pain without loss of consciousness is defined as analgesia. Regional anaesthesia is the temporary elimination of pain and nerve transmission in specific body areas with local anaesthetic drugs without inducing unconsciousness. When comparing regional anaesthesia to general anaesthesia, the frequency of its use is increasing.1,2 This is due to early mobilisation, the high analgesia level that can be achieved, diminished duration of hospital stays and lower post-operative nausea and vomiting.2 In addition, due to the recent rise in the use of ultrasonography, regional anaesthesia techniques are performed more reliably and effectively.3 In order to conduct a procedure or intervention that is in the patient’s best interest and will aid both the patient and the healthcare system as a whole, regional anaesthesia techniques are frequently used. Patients, healthcare providers, and institutions place a high value outcome such as mortality, readmissions, care safety and efficacy, patient satisfaction, cost-care ratios and timeliness of care provided. Thus, the perioperative team must work to ensure the best outcome for each patient. Knowledge of outcomes, benefits and risks is essential for the patient to be able to provide informed consent as well. Regional analgesia techniques diminish the neuroendocrine response to stress, thromboembolic phenomena and the use of parenteral analgesics in the post-operative period. The duration of effective analgesia is determined by the dose and concentration of local anaesthetics. The greater the volume and concentration of the local anaesthetic agent, the higher the possibility of local anaesthetic systemic toxicity. Opioids, when added as adjuvants, prolong post-operative pain relief accompanied by improved quality of analgesia. However, their usage can lead to side effects such as urinary retention, sedation and pruritis.4

Sub-arachnoid block or spinal anaesthesia is a common mode of anaesthesia that is used for orthopaedic surgeries of the lower limb.5

The anaesthetic ropivacaine has a prolonged duration of action. It is an S-enantiomer amide6 that is enantiomerically pure and exhibits low lipid solubility and a high pKa. It inhibits Aδ and C nerve fibres that transmit pain more potently than Aβ fibres that regulate motor function. The effect of ropivacaine occurs via reversible inhibition of nerve impulse conduction by reducing cell membrane permeability to sodium ions.

Bupivacaine hydrochloride is a long-acting amide anaesthetic. It is a commonly used local anaesthetic drug in sub-arachnoid blocks.7 Its uses include as intraoperative local anaesthetic agent, post-operative analgesia and treatment of chronic pain. Bupivacaine’s mechanism of action is thought to be similar to that of other local anaesthetics, in that it prevents sodium ions from passing through the neuronal membrane and generating an action potential. In the exterior lipid layer of the neuronal membrane, competitive binding to calcium sites is hypothesised to take place, leading to secondary interference from mobile phosphate groups. Sodium ion passage is inhibited by preventing molecular membrane reconfiguration from the inactive state (sodium impermeable) to the active (sodium permeable) state.

Fentanyl is a synthetic opioid. It can be added as an adjuvant to local anaesthetic agents used intrathecally.8 Fentanyl has the notable characteristics of being rapidly eliminated from serum alongside having high potency. Additionally, it has the benefit of causing minimal histamine release. Due to its substantial tissue absorption, serum levels quickly decrease after reaching their peak concentrations, accompanied by decrease in levels in the brain. The analgesic effect of fentanyl lasts for 30 to 40 minutes.9 However, when administered in high doses, there is a possibility of a second peak of activity several hours later. This is due to the release of the bound drug from tissue reserves. The use of opioids as an adjuvant to local anaesthetic agents has a synergistic action on its sensory blockade effects without significantly affecting its sympathetic activity. Fentanyl is an adjuvant used extensively to local anaesthetic agents used intrathecally.

Ensuring the successful alleviation of pain is crucial for healthcare professionals attending to patients who are undergoing surgical procedures.10 Pain relief offers notable physiological advantages, which is why the assessment of pain management is progressively gaining importance as a measure of post-operative quality. The objective of managing pain after surgery is to minimize or eliminate discomfort and pain while keeping adverse effects to a minimum. The post-operative analgesic effects of fentanyl are well established. While bupivacaine is commonly used for lower limb orthopaedic surgeries, there is an increasing use of ropivacaine for the same.11 This study will allow us to compare post-operative analgesia in the two groups of patients and the analgesic choice to make for lower limb orthopaedic surgeries to reduce the need for rescue analgesia in the post-operative period primarily. Secondary objectives will include comparison of the onset, duration of analgesia, and duration of sensory and motor blockade, haemodynamic stability of patients, the requirement of 24 hours rescue analgesia and incidence of side effects between both groups.

Protocol

Objectives

Primary objective

To compare post-operative analgesia in patients receiving bupivacaine with fentanyl and ropivacaine with fentanyl in lower limb orthopaedic surgeries via Sub-arachnoid block.

Secondary objective

  • 1. To compare the onset, duration of analgesia, and duration of sensory and motor blockade in both groups.

  • 2. To study the haemodynamic stability of patients in both groups

  • 3. To compare the requirement of 24 hours, rescue analgesia in both groups

  • 4. To compare the incidence of side effects.

Methods

This is a comparative randomised parallel group study approved by the Institutional Ethical Committee, Datta Meghe Institute of Medical Sciences, Sawangi (M), Wardha.

Study setting

The study will be conducted at Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research (DMIHER), Acharya Vinoba Bhave Rural Hospital (A.V.B.R.H.).

Study design

  • 1. Study duration: two years

  • 2. Study area: Department of Anaesthesiology, Jawaharlal Nehru Medical College, Acharya Vinobha Bhave Rural Hospital

  • 3. Research design: Comparative randomised parallel group study

  • 4. Study population: Patients 18–60 years of age undergoing lower limb surgeries

Inclusion criteria

  • a) Patients willing to participate in the study

  • b) Patients aged between 18–60 years

  • c) Patients in American Society of Anaesthesiologists (ASA) Grade I and II

  • d) Patients willing to give written informed consent

  • e) Patients of either sex

Exclusion criteria

  • a) Patient’s refusal to participate in the study.

  • b) Patients with haemorrhagic diathesis.

  • c) ASA Grade III and above

  • d) Patients having allergy to test drugs

  • e) Patients with significant scoliosis or kyphosis

  • f) Pregnant patients

Sampling size

The study will be carried out on 66 adult patients of both sexes (33 patients in each group) fulfilling all inclusion criteria. They will be divided into two group randomly:

  • Group A (n = 33): Patients receiving bupivacaine 3 mL with fentanyl 25 μg

  • Group B (n = 33): Patients receiving ropivacaine 3mL with fentanyl 25 μg

Rationale for selected sample size

The sample size was calculated using the formula for sample size calculation from the difference of two means.

In order to calculate sample size for comparing two means, data inputted were

  • Confidence interval (two-sided): 95%

  • Power: 80%

Ratio of sample size (Group 2/Group 1): 1

  • Difference of mean: 0.584

  • Standard deviation: 0.842 (group A), 0.842 (group B)

  • Variance: 0.708964 (group A), 0.708964 (group B)

(Table 1)

Table 1. Input data for sample size.

Group 1Group 2Difference of mean*
Mean0.584
Standard deviation0.8420.842
Variance0.7089640.708964

Formula used for calculation of sample size:

n1=σ12+σ22/κz1α/2+z1β22
n2=κσ12+σ22z1α/2+z1β22

n1: sample size of group A n2: sample size of group B

σ1: standard deviation of group A σ2: standard deviation of group B

Δ: difference in group means

K: ratio of n1/n2

Z1-α/2: two-sided Z value

Z1-β: power

Calculated sample size:

Group A: 33, Group B: 33

Total: 66

(Table 2)

Table 2. Sample size of group A and group B.

Sample size group A33
Sample size group B33
Total sample size66

Statistical analysis

SPSS version 15.0 will be utilised for data analysis. To determine statistical significance, a mean P value below 0.05 will be considered significant when represented graphically.

Methodology

Patients fulfilling the inclusion criteria and scheduled for lower limb orthopaedic surgeries will be explained the procedure following which informed and written consent will be obtained. A detailed history will be taken from patients, followed by a thorough general examination. The procedure will be explained to the consenting patients preoperatively. The selected patients will be kept fasted as per fasting guidelines prior to the scheduled day of operation. Vital parameters of the patients such as pulse rate, respiratory rate, oxygen saturation (SpO2), blood pressure and electrocardiogram (ECG) will be recorded in the preoperative room. The selected patients will be divided into two random groups by use of a computer-generated table. Each group will consist of 30 patients each, group A with patients who will receive bupivacaine and fentanyl and group B with patients who will receive ropivacaine and fentanyl. Prior to the administration of anaesthesia, patients will be informed of the study and its techniques again. A Multipara monitor will be connected to the patient. Baseline readings of heart rate, blood pressure and oxygen saturation will be noted before the start of the procedure. The above-mentioned parameters will be recorded after anaesthesia administration. Patients will be coloaded with 2 mL/kg of Ringer lactate after securing intravenous access with a 20G I.V. cannula. The procedure will be confirmed, and the patient will be explained the technique again. Under all aseptic precautions, sub-arachnoid block will be given with the patient in sitting/lateral position. 25G Quincke needle will be introduced in L3-L4 interspace. Bupivacaine 3 mL with fentanyl 25 μg for group A and ropivacaine 3 mL with fentanyl 25 μg with fentanyl for group B will be administered. The patient will be immediately made supine, following which the table orientation will be adjusted for the block to reach a spinal level of T12. The onset of sensory anaesthesia will be checked with pinprick method. Quality of motor block will be assessed by utilization of the Modified Bromage Scale. Pinprick testing in the mid-clavicular line will be used to check the sensory blockade regression time up to S2 bilaterally. Once the sensory block to S2 and motor block in the lower limbs have fully regressed, evaluations will stop. A >20% drop in systolic blood pressure from the baseline blood pressure, i.e., hypotension, will be treated with IV injection of ephedrine 0.25 to 1 mg/kg or IV fluids or both based on requirements. Atropine 0.6 mg IV injection will be administered to treat bradycardia, which is defined as a drop-in heart rate below 50 beats per minute. Intraoperatively, no analgesia will be given through the intravenous route. Injection diclofenac kept as rescue analgesia if needed. The amount of time (in minutes) from the first instance of urination will be noted; bladder catheterisation will only be carried out if surgically necessary. The need for rescue analgesia will also be noted, and inj. diclofenac 75 mg intramuscularly (i.m.) will be administered on VAS score of 4 post-operatively. The following parameters will be observed and recorded: Heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), pulse rate (PR) and percent of haemoglobin saturated with oxygen (SpO2) will be recorded: baseline values: before (drug administration) and after drug administration at every hour for 24 hours. Loss of sensation to pinprick will be used to establish the upper and lower spread of sensory block, and the Modified Bromage Scale will be used to evaluate motor block.

Post-operative pain analysis

Visual analog scale (VAS)

Patients will receive thorough preoperative instruction. Rescue analgesia will be given at a VAS score of 4 or above in the post-operative ward after the scores have been evaluated using the VAS scale (Table 3).

Table 3. VAS scores.

0 to 2No pain
2 to 4Mild pain
4 to 6Moderate pain
6 to 8Severe pain
8 to 10Unbearable pain

Block evaluation

Sensory block

Utilising a 27 G needle, the level of sensory block will be assessed, making use of the pinprick method, along the mid clavicular line. The level will be tested from the start of sensory block level reaching T6 level, every two minutes until the maximum sensory block is reached. The period of time from the termination of the injection of anaesthetic agent to the loss of sensation to a pinprick at the T10 level is considered as the onset of sensory blockade (Table 4).

Duration of sensory blockade

The assessment of duration of sensory blockade will be conducted by use of the two segment regression technique. It will involve the measurement of the time period from administration of local anaesthetic agent till the regression of maximum level of sensory blockade by two segments.

The grade of sensory block will be noted (Table 4). The time required for regression of blockade will be noted.

Table 4. Grades of sensory blockade.

0Sharp pain
1Analgesia
Dull sensation
2Anaesthesia
No sensation

Motor blockade

The quality of motor block will be assessed with the Modified Bromage Scale (Table 5).

Table 5. Modified Bromage Scale.

ScoreCriteria
1Complete block (unable to move feet or knees)
2Almost complete block (able to move feet only)
3Partial block (just able to move knees)
4Detectable weakness of hip flexion while supine (full flexion of knees)
5No detectable weakness of hip flexion while supine
6Able to perform partial knee bend

Onset of motor blockage: The time period between administration of sub-arachnoid block and development of Bromage level 3 of motor block.

Initiation of surgery will proceed only after establishment of complete anaesthesia.

Following the start of surgery, periodic testing for both motor and sensory levels will be carried out.

In the post-operative period, we will record the time required for regression to level L1 along with the time required for regression from maximum level using two segment regression evaluation.

Post-surgery, pain levels of the subjects will be evaluated for the level of pain by making use of the VAS Scale in the recovery and post-operative room.

Dissemination

The findings of this study will be made available to the scientific community through publication in peer reviewed journals.

Study status

Control group data collection ongoing.

Discussion/conclusions

Anaesthesiologists play a crucial role in the prevention and alleviation of post-operative pain.12 However, it is concerning that a notable portion of patients still experience unsatisfactory levels of pain following surgery.13 Inadequate management of post-operative pain can have detrimental effects on the individual’s quality of life and hinder their functional recovery.14,15 Moreover, it increases the risk of developing persistent pain and long-term reliance on opioids. Global data indicate that post-operative pain for people undergoing orthopaedic surgery can range from mild to severe. For instance, the incidence of this discomfort is said to range from 41% to 45% in China, while it is said to be between 80% and 86% in the US. This protocol is for a comparative prospective study which will be conducted on 66 adult patients of both sexes posted for lower limb orthopaedic surgery. The aim of the study is to compare post-operative analgesia in patients receiving bupivacaine with fentanyl and ropivacaine with fentanyl in lower limb orthopaedic surgeries via sub-arachnoid block.

Numerous studies have demonstrated the early motor recovery in patients receiving intrathecal ropivacaine with fentanyl as an adjuvant when compared to patients that received intrathecal bupivacaine with fentanyl along with comparable sensory block. Studies have shown that the combination of bupivacaine and fentanyl leads to the elimination of visceral pain, decreased incidence of nausea, improved hemodynamic stability, and extended the duration of post-operative analgesia.4 Our study aims to compare post-operative analgesia in the two groups of patients and the need for rescue analgesia in either group in the post-operative period. This study will allow for comparison post-operative analgesia in the two groups of patients and the choice to be made for lower limb orthopaedic surgeries to reduce the need for rescue analgesia in the post-operative period.

Ethical considerations

The study was approved by the Institutional Ethical Committee, Datta Meghe Institute of Medical Sciences, Sawangi (M), Wardha. Ref. No. DMIMS (DU)/IEC/2022/95.

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 07 Aug 2023
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
Bhuyan S, Chandak A and Chakole V. Comparison of efficacy of intrathecal fentanyl as an adjuvant to bupivacaine and ropivacaine in lower limb orthopaedic surgeries for post-operative analgesia [version 1; peer review: awaiting peer review]. F1000Research 2023, 12:943 (https://doi.org/10.12688/f1000research.135208.1)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status:
AWAITING PEER REVIEW
AWAITING PEER REVIEW
?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 07 Aug 2023
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.